{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:40:42Z","timestamp":1794436842156,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Capital Characteristic Clinic Project","award":["Grant No. Z211100002921037"],"award-info":[{"award-number":["Grant No. Z211100002921037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00819-7","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:18:54Z","timestamp":1772601534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic application regarding PILE score and the pan-immune-inflammation value in diffuse large B-Cell Lymphoma"],"prefix":"10.1186","volume":"27","author":[{"given":"Chun","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"819_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103193","volume":"83","author":"K Sun","year":"2025","unstructured":"Sun K, Wu H, Zhu Q, et al. Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022. EClinicalMedicine. 2025;83:103193.","journal-title":"EClinicalMedicine"},{"issue":"5","key":"819_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ajh.26151","volume":"96","author":"S Susanibar-Adaniya","year":"2021","unstructured":"Susanibar-Adaniya S, Barta SK. 2021 update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management. Am J Hematol. 2021;96(5):617\u201329.","journal-title":"Am J Hematol"},{"issue":"1","key":"819_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12957-025-03833-y","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Xu J, Zhang L, et al. The association of immune-inflammation indices at multiple time points with treatment response and survival in advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors. World J Surg Oncol. 2025;23(1):195.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"819_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1186\/s12885-025-14391-7","volume":"25","author":"K Cui","year":"2025","unstructured":"Cui K, Lin J, Hong P, et al. The pan-immune-inflammation value predicts prognosis and chemotherapy-related adverse events in Wilms\u2019 tumor patients. BMC Cancer. 2025;25(1):979.","journal-title":"BMC Cancer"},{"issue":"3","key":"819_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41416-020-0894-7","volume":"123","author":"G FUC\u00e0","year":"2020","unstructured":"FUC\u00e0 G, Guarini V, Antoniotti C, et al. The pan-immune-inflammation value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials. Br J Cancer. 2020;123(3):403\u20139.","journal-title":"Br J Cancer"},{"key":"819_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.724443","volume":"12","author":"R Zeng","year":"2021","unstructured":"Zeng R, Liu F, Fang C, et al. PIV and PILE score at baseline predict clinical outcome of anti-PD-1\/PD-L1 inhibitor combined with chemotherapy in extensive-stage small cell lung cancer patients. Front Immunol. 2021;12:724443.","journal-title":"Front Immunol"},{"issue":"8","key":"819_CR7","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s12094-021-02560-6","volume":"23","author":"DC Guven","year":"2021","unstructured":"Guven DC, Yildirim HC, Bilgin E, et al. Pile: a candidate prognostic score in cancer patients treated with immunotherapy. Clin Transl Oncol. 2021;23(8):1630\u20136.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"819_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-025-00676-x","volume":"14","author":"C Cai","year":"2025","unstructured":"Cai C, Liu Y, Lu R, et al. Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities. Exp Hematol Oncol. 2025;14(1):83.","journal-title":"Exp Hematol Oncol"},{"issue":"9","key":"819_CR9","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.4045","volume":"35","author":"J Ichikawa","year":"2020","unstructured":"Ichikawa J, Ando T, Kawasaki T, et al. Role of platelet C-type lectin-like receptor 2 in promoting lung metastasis in osteosarcoma. J Bone Miner Res. 2020;35(9):1738\u201350.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"819_CR10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1158\/0008-5472.CAN-22-1890","volume":"83","author":"T Akiyama","year":"2023","unstructured":"Akiyama T, Yasuda T, Uchihara T, et al. Stromal reprogramming through dual PDGFR\u03b1\/\u03b2 blockade boosts the efficacy of anti-PD-1 immunotherapy in fibrotic tumors. Cancer Res. 2023;83(5):753\u201370.","journal-title":"Cancer Res"},{"key":"819_CR11","doi-asserted-by":"crossref","unstructured":"Can\u00e8 S, Van Snick J, Uyttenhove C, et al. TGF\u03b21 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism. J Immunother Cancer. 2021;9(2):e001798.","DOI":"10.1136\/jitc-2020-001798"},{"issue":"9","key":"819_CR12","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1021\/acs.molpharmaceut.7b00997","volume":"15","author":"S Shen","year":"2018","unstructured":"Shen S, Zhang Y, Chen KG, et al. Cationic polymeric nanoparticle delivering CCR2 siRNA to inflammatory monocytes for tumor microenvironment modification and cancer therapy. Mol Pharm. 2018;15(9):3642\u201353.","journal-title":"Mol Pharm"},{"key":"819_CR13","doi-asserted-by":"crossref","unstructured":"MA H T, LIU Y, YIN S Q, et al. RACGAP1 promotes tumor progression by influencing neutrophil recruitment and tumor cell proliferation in colorectal cancer. J Immunol. 2025;214(8):2087\u201397.","DOI":"10.1093\/jimmun\/vkaf111"},{"issue":"4","key":"819_CR14","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2025.14943","volume":"29","author":"K Li","year":"2025","unstructured":"Li K, Zeng X, Zhang Z, et al. Pan\u2011immune\u2011inflammatory values predict survival in patients after radical surgery for non\u2011metastatic colorectal cancer: a retrospective study. Oncol Lett. 2025;29(4):197.","journal-title":"Oncol Lett"},{"issue":"4","key":"819_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12026-023-09376-2","volume":"71","author":"H Qayoom","year":"2023","unstructured":"Qayoom H, Sofi S, Mir MA. Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis. Immunol Res. 2023;71(4):588\u201399.","journal-title":"Immunol Res"},{"key":"819_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110873","volume":"132","author":"B Lin","year":"2020","unstructured":"Lin B, Du L, Li H, et al. Tumor-infiltrating lymphocytes: warriors fight against tumors powerfully. Biomed Pharmacother. 2020;132:110873.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"819_CR17","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.4240\/wjgs.v16.i10.3142","volume":"16","author":"P Shayimu","year":"2024","unstructured":"Shayimu P, Awula M, Wang CY, et al. Serum nutritional predictive biomarkers and risk assessment for anastomotic leakage after laparoscopic surgery in rectal cancer patients. World J Gastrointest Surg. 2024;16(10):3142\u201354.","journal-title":"World J Gastrointest Surg"},{"key":"819_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejca.2021.03.043","volume":"150","author":"F Corti","year":"2021","unstructured":"Corti F, Lonardi S, Intini R, et al. The pan-immune-inflammation value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. Eur J Cancer. 2021;150:155\u201367.","journal-title":"Eur J Cancer"},{"key":"819_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1036890","volume":"12","author":"XC Yang","year":"2022","unstructured":"Yang XC, Liu H, Liu DC, et al. Prognostic value of pan-immune-inflammation value in colorectal cancer patients: a systematic review and meta-analysis. Front Oncol. 2022;12:1036890.","journal-title":"Front Oncol"},{"key":"819_CR20","doi-asserted-by":"crossref","unstructured":"Baykal S, Yilmaz H, Cinar N B, et al. The pan-immune-inflammation value: A novel independent predictive factor for overall survival in \u2265pT2a nonmetastatic renal cell carcinoma. Urol Oncol. 2025;43(6):395.e7-.e12.","DOI":"10.1016\/j.urolonc.2024.12.261"},{"key":"819_CR21","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2024-0217","volume":"68","author":"Y \u00d6zt\u00fcrk","year":"2025","unstructured":"\u00d6zt\u00fcrk Y, Kocaba\u015f M, Karak\u00f6se M, et al. Prognostic significance of the pan-immune-inflammation value (PIV) in patients with differentiated thyroid carcinoma. Arch Endocrinol Metab. 2025;68:e240217.","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"819_CR22","doi-asserted-by":"publisher","first-page":"2476870","DOI":"10.1080\/20565623.2025.2476870","volume":"11","author":"Y Xie","year":"2025","unstructured":"Xie Y, Yu Q, Zhu Y, et al. The value of peripheral blood inflammation markers in risk assessment and prediction of lung cancer. Future Sci OA. 2025;11(1):2476870.","journal-title":"Future Sci OA"},{"issue":"3","key":"819_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.52827\/hititmedj.1301431","volume":"5","author":"M Reis Aras","year":"2023","unstructured":"Reis Aras M, Afacan \u00d6zt\u00fcrk HB, Yilmaz F, et al. Does systemic immune inflammation index predicts survival in diffuse large B cell lymphoma patients? Hitit Med J. 2023;5(3):170\u20134.","journal-title":"Hitit Med J"},{"issue":"1","key":"819_CR24","doi-asserted-by":"publisher","DOI":"10.1515\/med-2023-0819","volume":"18","author":"F Su","year":"2023","unstructured":"Su F, Lian K. Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma. Open Med. 2023;18(1):20230819.","journal-title":"Open Med"},{"issue":"2","key":"819_CR25","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1111\/ajco.13806","volume":"19","author":"J Wu","year":"2023","unstructured":"Wu J, Zhu H, Zhang Q, et al. Nomogram based on the systemic immune-inflammation index for predicting the prognosis of diffuse large B-cell lymphoma. Asia Pac J Clin Oncol. 2023;19(2):e138\u201348.","journal-title":"Asia Pac J Clin Oncol"},{"key":"819_CR26","doi-asserted-by":"crossref","unstructured":"Ucar M A, Tombak A, Akdeniz A, et al. Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study. Medicina (Kaunas). 2025;61(6):1019.","DOI":"10.3390\/medicina61061019"},{"issue":"1","key":"819_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000543304","volume":"20","author":"M Y\u0131lmaz","year":"2025","unstructured":"Y\u0131lmaz M, Erdi\u015f E, U\u00e7ar M, et al. Prognostic Importance of Panimmune-Inflammation Value and PILE Scores in Non-Metastatic Luminal A Breast Cancer. Breast Care (Basel). 2025;20(1):27\u201339.","journal-title":"Breast Care (Basel)"},{"issue":"20","key":"819_CR28","first-page":"7679","volume":"26","author":"I Karada\u011f","year":"2022","unstructured":"Karada\u011f I, Karakaya S, Y\u0131lmaz ME, et al. The potential prognostic novel markers PIV and PILE score to predict survival outcomes at hepatocellular cancer. Eur Rev Med Pharmacol Sci. 2022;26(20):7679\u201386.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"819_CR29","doi-asserted-by":"publisher","unstructured":"Lokesh, K, Yaman, P, Darshan, R, et al. Role of Pretreatment Pan-Immune Inflammation Value as Predictive Marker of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Prospective Observational Study in a Tertiary Cancer Center Indian J Med Paediatr Oncol. 2026; Indian J Med Paediatr Oncol. https:\/\/doi.org\/10.1055\/s-0045-1811967.","DOI":"10.1055\/s-0045-1811967"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00819-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:31:07Z","timestamp":1775813467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00819-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00819-7","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research adhered to the principles outlined in the Declaration of Helsinki, obtained approval by the Ethics Committee of Aerospace Center Hospital (approval no. 2024037-02), and all patients and participants who involved in this study signed informed consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"I confirm the corresponding author has read the journal policies and submit this manuscript in accordance with those policies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}